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SObjective: Transcatheter aortic valve implantation is an emerging technique for the treatment of aortic valve
stenosis in high-risk patients. Detailed knowledge of aortic root anatomy, including specific information on
the extent of native cusp calcifications, is required. The aim of this study was to evaluate whether echocardio-
graphic assessment of aortic stenosis using a calcification score is useful to predict outcomes of transcatheter
aortic valve implantation in elderly high-risk patients.
Methods:Detailed preoperative digitalized transesophageal echocardiographic images were available from 103
patients treated by transapical transcatheter aortic valve implantation between February 2006 and February
2009. On the basis of a previously published study, an index score was developed to describe the extent of valve
calcification ranging from 0 to 8 (normal to diffuse calcification).
Results: The median age of patients was 82.2 5.9 years. The mean logistic European System for Cardiac Op-
erative Risk Evaluation was 33.0%  16.3%. Mild paravalvular leak was present in 43 patients (42.2%), and
a moderate paravalvular leak was observed in 5 patients (4.9%). Severe regurgitation was not observed in any
patient. Logistic regression analysis revealed that the transcatheter aortic valve implantation echocardiographic
calcification score is associated with the presence of moderate paravalvular aortic regurgitation (odds ratio, 8.5;
95% confidence interval, 1.2–58.9; P ¼ .0001) and overall moderate aortic regurgitation (odds ratio, 3.6; 95%
confidence interval, 1.2–10.4; P ¼ .0006).
Conclusions: Transesophageal echocardiography demonstrates detailed anatomic information of the calcifica-
tion patterns of the aortic valve and root and thus plays an important role in the screening of patients undergoing
transcatheter aortic valve implantation. The transcatheter aortic valve implantation echocardiographic calcifica-
tion score allowed prediction of the risk of postoperative paravalvular and overall aortic regurgitation. (J Thorac
Cardiovasc Surg 2011;142:1229-35)Aortic stenosis (AS) is themost frequent acquired heart valve
lesion in theWesternworld.Therapeutic intervention is based
on standardized guidelines, which have resulted in excellent
outcomes using conventional surgical valve replacement, in
young patients with a relatively low-risk profile1-3 and even
in octogenarians.4-7 Transcatheter aortic valve implantation
(TAVI) is a relatively new therapeutic option to treat elderly
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The Journal of Thoracic and Carto conventional surgical aortic valve replacement.8,9 In
contrast with surgery, TAVI does not involve excision of the
diseased native valve or annular tissue. The metal stent of
the implanted device leads to compression of native valve
cusps and associated calcification against the aortic annulus
and aortic wall. Paravalvular leak around the valve stent is
known to occur in a significant proportion of patients
undergoing TAVI, but the precise mechanism behind this
phenomenon remains unclear. Paravalvular leak may be
related to specific anatomy (in particular, a noncylindric
shape) of the annulus or aortic root, or to the amount and
distribution of leaflet and annular calcification. Trans-
thoracic echocardiography (TTE) is routinely used for the
diagnosis of AS and for postoperative functional asses-
sment after valve surgery. Transesophageal echocar-
diography (TEE) is frequently used for the preoperative
screening of patients undergoing TAVI and during the
procedures to assess valve and ventricular function. The
routine use of TEE may permit a systematic preoperative
analysis of the anatomy of the aortic valve and root, and in
particular may allow for better characterization of aortic
valve calcification. Improved characterization of aorticdiovascular Surgery c Volume 142, Number 5 1229
Abbreviations and Acronyms
AR ¼ aortic regurgitation
AS ¼ aortic stenosis
ECS ¼ echocardiographic calcification score
SD ¼ standard deviation
TAVI ¼ transcatheter aortic valve implantation
TEE ¼ transesophageal echocardiography
TTE ¼ transthoracic echocardiography
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of developing post-intervention aortic regurgitation (AR).
The current study was designed to investigate the perfor-
mance of a new echocardiographic calcium score in predict-
ing the occurrence of postoperative AR after TAVI.MATERIALS AND METHODS
Patients
The clinical charts of 212 consecutive patients who underwent transap-
ical TAVI using a SAPIEN prosthesis (Edwards Lifesciences, Irvine, Calif)
at the Leipzig Heart Center between February 2006 and February 2009
were retrospectively identified and reviewed.10
The first 50 patients of the series were excluded from the present anal-
ysis because they were considered to be part of the early phase of the sur-
gical and technical learning curve. Another 55 patients were excluded
because of the absence of high-quality digitalized preoperative TEE and
postoperative TTE examinations. Patients who underwent a valve-
in-valve procedure for severe post-implantation AR (n ¼ 4) were also
excluded from the analysis because they were considered as a technical
failure with an incorrect level of depth implantation. Thus, a total of 103
patients who received a theoretically well-positioned aortic valve prosthe-
sis (40%–50% of the valve stent above and 60%–50% below the aortic
annulus as recommended by themanufacturer) were included in the present
study.
Echocardiographic Assessment
Since January 2008, TEE has been used routinely for preoperative
screening and images stored digitally for all patients. The additional use
of TEE for preoperative screeningwas considered necessary to better under-
stand the morphology of the calcified aortic valve and to precisely measure
the aortic valve annulus. Patients with good quality and digitally stored TEE
images were included in this study. Echocardiographic studies were consid-
ered goodwhen the 3 aortic leaflets and the aortic commissures were clearly
identified on examination. TEE examinationswere performed using a Vivid
7 machine (General Electric, Milwaukee, Wis), and the images were stored
and archived in digital format. Offline image analysis and measurements
were carried out using a digital archiving and reporting system (EchoPAC
08, General Electric). Standard TEE examinations were performed with
special attention being paid to the aortic annulus, sinotubular junction, dis-
tribution and severity of valve calcification, andmitral annulus calcification.
Transaortic pressure gradients, aortic valve area, and valvular regurgitation
were determined according to published guidelines.11
Measurements of the aortic annulus and aortic leaflets were performed
using 2-dimensional imaging in long-axis (120–130 degrees) and short-
axis (45–60 degrees) views, both in end diastole (defined as the beginning
of the QRS). Complete postoperative TTE examination was performed on
all patients within 1 week after device implantation. ARwas assessed using
color Doppler, pressure half-time, vena contracta width, and flow reversal1230 The Journal of Thoracic and Cardiovascular Surtechniques. The ARwas classified as paravalvular, transvalvular, or both by
using the assessment scheme used byMoss and colleagues12 and Kapur and
colleagues.13
Calcification Score Index
Corciu and colleagues14 described and validated the calcification score
index, a semiquantitative echocardiographic cardiovascular score using
relatively simple transthoracic echocardiographic parameters (anterior mi-
tral annular calcification, aortic valve sclerosis, and aortic root sclerosis)
permitting better characterization of the risk of developing cardiovascular
disease. We modified this score and added information on calcification of
specific structures of the aortic root (ie, aortic annulus, sinotubular junc-
tion, and aortic valve commissures) that we considered potentially impor-
tant to assess the risk of postoperative AR after TAVI (Table 1).
The independent components of the resultant calcification scoring sys-
tem were then analyzed univariately for possible associations with the
development of postoperative paravalvular AR and transvalvular AR.
Those variables with a P value less than .10 were then identified and
analyzed. The variables identified were the aortic commissures and the 3
aortic valve cusps: right coronary cusp, left coronary cusp, and noncoro-
nary cusp.
AR was dichotomized into group A (none or trivial/mild) and group B
(moderate). The dichotomization was deemed clinically appropriate
because trivial/mild regurgitation is considered to be a benign and nonpro-
gressive process in the majority of patients.15 The results of the calcifica-
tion score index variables and new variables added are given in Table 2.
The results of the statistical univariate analyses are presented in Tables 3
and 4.The sum of calcification scores obtained from the 3 aortic cusps and
commissures (those variables that were demonstrated to have a univariate
association with development of post-TAVI AR) was called the TAVI echo-
cardiographic calcification score (ECS). The TAVIECS ranged from0 (nor-
mal native aortic valve) to 8 (diffuse calcification of all 3 aortic cusps and
commissures). Illustrative examples of echocardiographic images are
shown in Figure 1.
We also considered the grade of prosthesis oversizing as a potential vari-
able affecting the presence of postimplantation AR. Oversizing was calcu-
lated as the difference between the diameter of the prosthesis implanted (ie,
23 or 26 mm) and the annulus size as measured by TEE using 2-dimen-
sional imaging in a long-axis view (120–130 degrees). Oversizing was
further classified into absent (0 and 1 mm), normal (2 and 3 mm), and ex-
cessive (>3 mm), and tested for the presence of paravalvular AR and trans-
valvular AR. The results of this analysis are shown in Tables 3 and 4.
Statistical Analysis
Patient characteristics were summarized using percentages when the
variables were categoric and as mean or median values when the variables
were continuous. The Mann–Whitney test was used to compare continuous
variables, and the Fisher exact test was used for binary variables. Logistic
regression analysis was used to assess the associations between the pres-
ence of a postoperative paravalvular AR or transvalvular AR and the vari-
ables of the calcification score. Odds ratio and corresponding 95%
confidence intervals were estimated. The inter- and intraobserver reproduc-
ibility of TAVI ECS were evaluated using Bland–Altman analysis by
calculating the bias (mean difference) and the 95% limits of agreement
(2 standard deviation [SDs] around the mean difference).RESULTS
Study Population
The median age of patients was 82.2  5.9 years (range
64.3–97.5 years), and 55 of 103 patients (53.4%) were fe-
male. The mean logistic European System for Cardiac Op-
erative Risk Evaluation was 33.0%  16.3%. TEE meangery c November 2011
TABLE 1. Characteristics of the original variables of the calcification
score index and the new variables added (modified from 20)
Original variables of calcification score index
Aortic root:
Normal echogenicity, wall thickness<2.2 mm 0
Enhanced echogenicity, wall thickness  2.2 mm 1
Porcelain aorta 2
Mitral annular calcification:
Normal echogenicity 0
Mild calcification (thickness<2 mm, length<5 mm) 1
Moderate calcification (thickness>2 mm, length>5 mm) 2
Severe calcification (‘‘shadowing’’) 3
Aortic valve cusps:
RCC normal echogenicity, flexible motion 0
Enhanced echogenicity, reduced motion 1
Complete calcification, stiffness, no motion 2
LCC normal echogenicity, flexible motion 0
Enhanced echogenicity, reduced motion 1
Complete calcification, stiffness, no motion 2
NCC normal echogenicity, flexible motion 0
Enhanced echogenicity, reduced motion 1
Complete calcification, stiffness, no motion 2
New variables added
Aortic valve commissures:
Normal echogenicity, all 3 open 0
Enhanced echogenicity, fusion 1 commissure 1
Severe calcification, multiple fusions 2
Aortic annulus:
Normal echogenicity 0
Localized calcification(s) 1
Circularly complete calcification 2
Sinotubular junction:
Normal echogenicity 0
Localized calcification(s) 1
Circularly complete calcification 2
CSI, calcification score index; RCC, right coronary cusp; LCC, left coronary cusp;
NCC, noncoronary cusp.
TABLE 2. Results of the calcification score index variables and new
variables added
Calcification score index variables and
new variables added Patients (%)
Aortic root
0 7 (6.80)
1 78 (75.73)
2 18 (17.48)
Aortic annulus
0 10 (9.71)
1 70 (67.96)
2 23 (22.33)
RCC
0 5 (4.85)
1 56 (54.37)
2 42 (40.78)
LCC
0 6 (5.83)
1 56 (54.37)
2 41 (39.81)
NCC
0 4 (3.88)
1 31 (30.10)
2 68 (66.02)
Aortic commissure
0 8 (7.77)
1 50 (48.54)
2 45 (43.69)
MAC
0 21 (20.39)
1 58 (56.31)
2 24 (23.3)
Sinotubular junction
0 3 (2.91)
1 81 (78.64)
2 19 (18.45)
Mean ‘‘new’’ CSI  SD 10.09  2.69
RCC, Right coronary cusp; LCC, left coronary cusp; NCC, noncoronary cusp; MAC,
mitral annular calcification; CSI, calcification score index; SD, standard deviation.
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Saortic annulus dimension during end diastole was 22.5 
1.5 mm (range, 18–26 mm). Preoperatively, the mean aortic
valve area was 0.5 0.2 cm2 (range, 0.2–1.1 cm2), the mean
left ventricular ejection fraction was 54.9%  11.2%, the
mean peak aortic valve gradient was 72.6  2.5 mm Hg,
and the mean average aortic valve gradient was 47.2 
19.9 mm Hg. The mean calcification score index with the
new variables added for aortic valve was 10.1  2.7 (range,
1–16). Scores for individual characteristics of the valve and
aortic root are listed in Table 2. Scores 10, 9, and 12 were
the most frequent and were present in 18 patients
(17.5%), 16 patients (15.5%), and 16 patients (15.5%),
respectively.
Postimplantation Prosthetic Valve Assessment
A total of 27 patients (26.2%) received a 23-mm SA-
PIEN prosthesis, and 76 patients (73.8%) received a 26-
mm SAPIEN prosthesis. Seven patients (6.9%) were found
to have isolated central AR post-procedure. ParavalvularThe Journal of Thoracic and CarAR was absent in 55 patients (53%), a mild paravalvular
leak was present in 43 patients (42%), and a moderate para-
valvular leak was observed in 5 patients (5%). The overall
grade of AR was similarly distributed with 50% of patients
exhibiting no regurgitation, 43% of patients with mild AR,
and 7% of patients with moderate AR. The postoperative
mean aortic valve gradient was 8.5  3.1 mm Hg, and the
mean peak aortic valve gradient was 15.9  5.3 mm Hg.Transcatheter Aortic Valve Implantation
Echocardiographic Calcification Score
In the study population, the TAVI ECS ranged from 1 to
8. ATAVI ECS of 6, 7, or 8 was the most frequent and pres-
ent in 20 patients for each score value (19.4% each). A total
of 16 patients (15.5%) had a score of 4, 15 patients (14.6%)
had a score of 5, 6 patients (5.8%) had a score of 3, 4diovascular Surgery c Volume 142, Number 5 1231
TABLE 3. Univariate association among calcification score index, new
variables added, and prosthesis oversizing with paravalvularaortic
regurgitation
Variables
No. of patients
with AR/N (%) OR 95% CI P
Aortic root
0 0/7 (0) Reference .95
1 5/78 (6.4) Reference
2 1/18 (5.5) 0.94 0.10–8.58
Aortic annulus
0 1/10 (10) Reference .19
1 2/70 (2.9) 0.26 0.22–3.22
2 3/23 (13) 1.35 0.12–14.82
RCC
0 0/5 (0) Reference
1 0/56 (0) Reference
2 6/42 (14.3) 13.31 1.8–N .003
LCC
0 0/6 (0) Reference .02
1 1/56 (1.8) Reference
2 5/41 (12.2) 8.47 0.95–75.41
NCC
0 0/4 (0) Reference
1 0/31 (0) Reference
2 6/68 (8.8) 4.48 0.62–N .09
Aortic commissure
0 0/8 (0) Reference .005
1 0/50 (0) Reference
2 6/45 (13.3) 11.71 1.63–N
MAC
0 1/21 (4.8) Reference .32
1 5/58 (8.6) 1.87 0.19–93.64
2 0/24 (0) 0.875 0.01–34.13
STJ
0 0/3 Reference .36
1 4/81 (4.9) Reference
2 2/19 (10.5) 2.35 0.39–13.90
PHVoversize
Normal 2/63 (3.2) Reference .33
Absent 2/16 (12.5) 4.36 0.56–33.65
Excessive 2/24 (8.3) 2.77 0.36–20.89
AR results were dichotomized into group A (none or trivial/mild) and group B (mod-
erate). AR, Aortic regurgitation; OR, odds ratio; CI, confidence interval;MAC,mitral
annular calcification; STJ, sinotubular junction; PHV, prosthetic heart valve; RCC,
right coronary cusp; LCC, left coronary cusp; NCC, noncoronary cusp.
TABLE 4. Univariate association among calcification score index, new
variables added, and prosthesis oversizing with transvalvular aortic
regurgitation
Variables
No. of patients
with AR/N (%) OR 95% CI P
Aortic root
0 0/7 (0) Reference
1 5/78 (6.4) Reference .45
2 2/18 (11.1) 2 0.34–11.23
Aortic annulus
0 0/10 (0) Reference
1 5/70 (7.1) Reference .68
2 2/23 (8.7) 1.43 0.26–7.9
RCC
0 1/5 (20) Reference
1 3/56 (5.4) 0.23 0.02–2.71 .56
2 3/42 (7.2) 0.31 0.03–3.70
LCC
0 1/6 (16.7) Reference
1 2/56 (3.6) 0.19 0.01–2.42
2 4/41 (9.8) 0.54 0.05–5.85 .32
NCC
0 0/4 (0) Reference
1 1/31 (3.2) Reference
2 6/68 (8.8) 3.29 0.38–28.47 .22
Aortic commissure
0 1/8 (13) Reference
1 1/50 (2) 0.14 0.01–2.55 .14
2 5/45 (11.1) 0.88 0.09–8.66
MAC
0 3/21 (14.3) Reference
1 3/58 (5.2) 0.33 0.06–1.77
2 1/24 (4.2) 0.26 0.02–2.72 .36
STJ
0 0/3 (0) Reference
1 5/81 (6.2) Reference
2 2/19 (10.5) 1.86 0.33–10.40 .49
PHVoversize
Normal 5/63 (7.9) Reference
Absent 1/16 (6.3) 0.77 0.08–7.13
Excessive 1/24 (4.2) 0.50 0.06–4.55 .8
AR results were dichotomized into group A (none or trivial/mild) and group B (mod-
erate). AR, Aortic regurgitation; OR, odds ratio; CI, confidence interval;MAC,mitral
annular calcification; STJ, sinotubular junction; PHV, prosthetic heart valve; RCC,
right coronary cusp; LCC, left coronary cusp; NCC, noncoronary cusp.
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Spatients (3.9%) had a score of 1, 2 patients (1.9%) had
a score of 2, and no patient had a score of 0. The TAVI
ECS correlated significantly with the presence of moderate
paravalvular AR. The TAVI ECS was not significantly cor-
related with the presence of transvalvular AR (Table 5).
Oversizing of the Implanted Prosthesis
The mean amount of prosthesis oversizing was 2.6  1.2
mm. An oversizing of 2 and 3 mm was the most frequently
observed, occurring in 32 patients (31%) and 31 patients
(30%), respectively. We failed to find any statistically sig-
nificant correlation between the amount of oversizing and1232 The Journal of Thoracic and Cardiovascular Surthe development of post-procedure paravalvular and trans-
valvular AR (Figure 2).
The Bland–Altman analysis of TAVI ECS revealed a non-
significant bias in interobserver (0.2 [2 SD,1.1 to 1.5]) and
intraobserver (0.4 [2 SD,1.0 to 1.8]) measurements. The
Bland–Altman analysis for TAVI ESS also resulted in a non-
significant bias in interobserver (0.3 [2 SD,1.2 to 1.7]) and
intraobserver (0.4 [2 SD,1.0 to 1.8]) measurements.
DISCUSSION
TAVI has been introduced as an alternative approach to
the surgical treatment of patients with AS and highgery c November 2011
FIGURE 1. Illustrative examples of different calcification patterns (A–C) using echocardiographic images, corresponding schematic drawings, and score
values for variables. RCC, Right coronary cusp; LCC, left coronary cusp; NCC, noncoronary cusp and aortic commisures.
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Soperative risk. Favorable clinical results have been de-
scribed.15,16 As stated by the early experience of the
Vancouver group,12 preoperative and intraoperative TEE
has assumed a central role for successful sizing and perio-
perative analysis during deployment of the prosthetic valve.
In accordance with the findings of Moss and col-
leagues,12 we observed a distribution of paravalvular leaks
that was inhomogeneous in our patient population after
TAVI.Wewere unable to demonstrate a correlation between
the presence of annular calcification and the development of
postoperative AR. We were only able to observe a modest
trend between the amount of commissural calcification
and the presence of a paravalvular leak.
Our analysis of all individual calcification scores for
each component of the aortic root showed that calcification
of the commissures and the aortic valve cusps is most crit-
ical when assessing the risk of post-intervention AR. The
univariate analysis of commissure scores showed that the
highest score of 2 was significantly associated with the
presence of moderate postoperative paravalvular ARThe Journal of Thoracic and Car(P ¼ .0057). This finding is in accordance with our initial
hypothesis that the presence of calcification at the level of
the aortic commissures does not permit the stent of the
prosthetic valve to reach a complete alignment with the
aortic wall, which may lead to the presence of postopera-
tive paravalvular leaks. The results of the present study
also indicate a significant correlation between a high
TAVI ECS and the presence of moderate paravalvular
AR (P ¼ .0001). The presence of bulky calcification at
the level of the commissures and leaflet cusps probably
prevents adequate alignment of the metal stent against
the aortic wall, with a resultant defective seal between
these structures.
The present results suggest that the use of the TAVI ECS,
as well as the aortic commissure calcification score alone,
can predict the development of moderate postoperative par-
avalvular AR. Another important observation is the fact that
oversizing by 2 to 3 mm was associated with less paravalv-
ular and transvalvular AR when compared with smaller or
higher degrees of oversizing (Figure 2). Such a finding isdiovascular Surgery c Volume 142, Number 5 1233
FIGURE 1. (continued).
TABLE 5. Univariate association among transcatheter aortic valve
implantation echocardiographic calcification score, paravalvular
aortic regurgitation, and transvalvular aortic regurgitation
Variables OR 95% CI P
Paravalvular AR TAVI ECS 8.5 1.2–58.9 .0001
Transvalvular AR TAVI ECS 1.2 0.7–1.8 .48
OR, Odds ratio; CI, confidence interval; AR, aortic regurgitation; TAVI, transcatheter
aortic valve implantation; ECS, echocardiographic calcification score.
FIGURE 2. Distribution of patients with trivial/mild and moderate
paravalvular leak by amount of prosthetic valve oversizing (absent: 0 and
1 mm; normal: 2 and 3 mm; excessive:>3 mm). AR, Aortic regurgitation.
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Sparticularly important because it implies that a wider range
of sizes for the SAPIEN prosthesis, as well as for all other
potential transcatheter heart valves, should be available
for clinical implementation.
We also observed that excessive oversizing was associ-
ated with a greater number of patients presenting with triv-
ial/mild transvalvular AR. This finding could be explained1234 The Journal of Thoracic and Cardiovascular Surby the fact that overexpansion of the stent may lead to de-
creased leaflet coaptation, which in turn leads to central val-
vular incompetence. From a clinical standpoint, it is
important to mention that the observed central regurgitation
was not clinically relevant in any patient and that it later re-
solved during follow-up echocardiography in the majority
of patients.
We agree with Moss and colleagues12 that difficulties
observed in accurately assessing paravalvular AR with
standard echocardiographic methods remain a clinical chal-
lenge. In contrast with these authors, however, we reported
our results in terms of none, trivial/mild, or moderate para-
valvular AR because we strongly believe that this issue
needs to be more fully addressed. Because TAVI has be-
come a clinical reality in a large number of cardiac centers,
more thorough comparison with the gold standard (ie, the
conventional aortic valve replacement surgery) will be re-
quired, and the issue of paravalvular leakage will need to
be more fully addressed.17
On the basis of the experience of conventional aortic
valve surgery, it seems unlikely that trivial or mild degrees
of AR will translate into major clinical issues, at least in the
early postoperative period. In our study, 53% of patients
presented without any paravalvular leak, 42% of patients
presented with trivial/mild AR, and 5% of patientsgery c November 2011
Colli et al Evolving Technology/Basic Sciencepresented with moderate AR, comparing favorably with the
literature.12,15,18
We believe the clinical results of TAVI are promising.
However, the presence of paravalvular AR is frequent,
and larger studies with a longer follow-up are needed to de-
termine the progression and significance of paravalvular
AR. We agree with Clavel and colleagues18 that the uncer-
tainty about paravalvular AR progression and prosthesis du-
rability will play a more prominent role as these therapies
are offered to progressively younger patients. The accep-
tance of paravalvular leakage post-TAVI may result in an-
other ‘‘paradigm shift’’ in valvular therapy.19 Newer
generation transcatheter prostheses will need to focus on
this issue, however, especially if younger patients are to
be considered for therapy.19E
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SLimitations
First, the present study is limited by the relatively small
sample size of 103 patients leading to some statistical
limitations.
Second, the association between TAVI ECS and post-
intervention AR was tested only in patients undergoing
transapical TAVI with a SAPIEN valve, and we do not
know the applicability of this scoring system to other deliv-
ery access methods (transfemoral or trans-subclavian valve
implantation) or other devices.
Third, as demonstrated by Ng and colleagues,20 preoper-
ative 2- and 3-dimensional TEE examinations underesti-
mate the annular/left ventricular outflow tract geometries
with respect to the planimetry areas calculated with multi-
slice computed tomography.
Fourth, the use of 2-dimensional echocardiography for
the assessment of cusps and commissures calcifications
may be limited by insufficient imaging or difficulties
achieving an appropriate parallel plane to the aortic annulus
(the nadirs of the aortic sinuses lie in a plane tilted 30 de-
grees from the horizontal).
Fifth, the echocardiography-based calcium scoring sys-
tem has not been cross-validated with multislice computed
tomography, which is known to be the gold standard imag-
ing technique to assess and quantify calcium in the aortic
valve.21,22CONCLUSIONS
Calcification of the aortic valve and commissures is asso-
ciated with the development of post-TAVI AR. The semi-
quantitative TAVI ECS was found to be a simple and
reproducible instrument to evaluate the anatomic structures
of the calcified aortic root. TAVI ECS may be used to iden-
tify patients at high risk for the development of post-
intervention AR on the basis of their aortic valve calcifica-
tion patterns and may therefore aid in future decision-
making regarding TAVI therapy.The Journal of Thoracic and CarReferences
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